This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0409U only for LiquidHALLMARK® from Lucence Health Inc. The test uses next–generation sequencing (NGS) to evaluate circulating cell–free DNA and RNA from a plasma specimen for alterations to 80 and 36 genes, respectively, and reports any identified mutations along with a guide to possible clinically actionable treatment options.
For clinical responsibility, terminology, tips and additional info
start codify free trial.